Study shows long-term cannabis use disrupts critical brain processes
Heavy lifetime cannabis use is associated with reduced brain activation in key cognitive regions, particularly during working memory tasks, while recent use may cause temporary cognitive impairments.
View ArticleResearch highlights burden of cannabinoid hyperemesis syndrome
A new study analyzes the disease burden and the risk factors for severity among people who suffer from a condition called cannabinoid hyperemesis syndrome.
View ArticleStudy reveals role of CB1 receptors in resilience to chronic stress
When faced with chronic stress, why do some people develop anxiety and depressive symptoms while others show resilience?
View ArticleThe Future of CBD research, marketing, and regulation
In this interview, Professor Ted Dinan, Medical Director at Atlantia Clinical Trials, and Asa Waldstein, Principal at Supplement Advisory Group, discuss Atlantia’s expertise in clinical trials for CBD.
View ArticleNew drug VIP36 shows promise in treating pain without harmful side effects
A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain.
View ArticleMaternal cannabis use linked to increased risk of behavioral problems in...
Children exposed to their mother's cannabis use during pregnancy and after birth are three times more likely to develop behavioral problems, new Curtin University research has found.
View ArticleUN Commission on Narcotic Drugs places six substances under international...
Following recommendations by the World Health Organization (WHO), the United Nations Commission on Narcotic Drugs (CND) has decided to place five new psychoactive substances and one medicine under...
View ArticleCB1R inhibition shows promise in protecting gut barrier from alcohol damage
Heavy alcohol consumption is a leading cause of gastrointestinal diseases, with binge drinking linked to increased intestinal permeability-a condition commonly known as "leaky gut."
View ArticleACP issues Best Practice Advice on cannabis for chronic pain management
The American College of Physicians (ACP) has issued Best Practice Advice for clinicians whose patients are considering or using cannabis or cannabinoids for management of chronic, noncancer pain.
View ArticleUQ's new research center aims to improve lives of people living with pain
One of the world's foremost pain experts has highlighted the risks of bypassing established processes for assessing the safety and effectiveness of medicines at the launch of a research center at the...
View Article